法尼甾体X受体
受体
胆汁酸
核受体
肝X受体
信号转导
G蛋白偶联胆汁酸受体
胆固醇
生物
免疫系统
脂质代谢
细胞信号
新陈代谢
生物化学
免疫学
转录因子
基因
作者
Shangwen Qi,Xu Luo,Shuangfang Liu,Bishi Ling,Hua Jin
出处
期刊:Journal of Cardiovascular Pharmacology
[Ovid Technologies (Wolters Kluwer)]
日期:2022-10-01
卷期号:80 (4): 562-573
被引量:7
标识
DOI:10.1097/fjc.0000000000001320
摘要
Atherosclerosis (AS) is one of the most common cardiovascular diseases and is the leading cause of arteriosclerotic cardiovascular disease. Bile acids are not only the products of cholesterol metabolism, but also an important class of signaling molecules. Bile acids exert their biological effects through the bile acid receptor signaling pathways. Bile acid receptors are widely distributed in human organs and tissues. The activation of transcriptional and signaling cascades controls bile acid metabolism and synthesis, lipid and carbohydrate metabolism, immune cell expression, and inflammatory responses. A large body of evidence indicates that bile acids play an important role in the initiation and development of AS, and are strongly associated with AS risk factors. The major bile acid receptors, nuclear receptor farnesoid X receptor (liver) and membrane receptor G protein-coupled receptor 5, exhibit anti-atherosclerotic effects. Other nuclear receptors exert different anti-atherosclerotic or pro-atherosclerotic effects. In this review, we summarize the current knowledge on the effects of bile acids and their receptors in AS and explore the pathway of bile acids involved in atherosclerotic lesions. The main research based on animal models or cell/tissue culture experiments is also discussed. This review provides new ideas for the development of novel therapeutic approaches for AS prevention and treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI